Download FREE Report Sample
Download Free sampleVoriconazole is a broad-spectrum antifungal agent for fungal infections in humans and animals.
Voriconazole Vfend Market contains market size and forecasts of Voriconazole Vfend in Global, including the following market information:
Global Voriconazole Vfend Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Voriconazole Vfend market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Voriconazole Vfend include Pfizer, Apotex, Accord Healthcare, Mylan Pharmaceuticals, Pharmascience (Joddes), Auro Pharma, Roche, Macherey-Nagel GmbH and Jincheng HEALTH Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Voriconazole Vfend companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Voriconazole Vfend Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Voriconazole Vfend Market Segment Percentages, by Type, 2021 (%)
Injection
Tablets
Capsule
Global Voriconazole Vfend Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Voriconazole Vfend Market Segment Percentages, by Application, 2021 (%)
For People
For Animal
Global Voriconazole Vfend Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Voriconazole Vfend Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Voriconazole Vfend revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Voriconazole Vfend revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Apotex
Accord Healthcare
Mylan Pharmaceuticals
Pharmascience (Joddes)
Auro Pharma
Roche
Macherey-Nagel GmbH
Jincheng HEALTH Pharmaceutical
Takeda
Novartis
Aditya Pharma
Daiichi Sankyo
Taj Pharmaceuticals
Sandoz
Ebang Pharmaceutical
GSK
Teva
Cilag AG
Squibb
Abbott
Livzon Pharmaceutical Group
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng Haisi Pharmaceutical
Zhuhai Yibang Pharmaceutical
Beijing Bokang Gene Technology
Chengdu Taihe Health Technology Group
Yangtze Pharmaceutical Group
Hubei Wushi Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy